Vive Organic Raises $13M Funding To Expand Wellness Line
Vive Organic Raises $13M Series B from Cambridge SPG, Monogram Capital and Powerplant Ventures to Expand Immunity Building Wellness Line.
Immunity-boosting beverage company Vive Organic has closed a $13 million series B funding led by Monogram Capital with participation by Cambridge Companies SPG and PowerPlant Ventures that also led its earlier fundraising.
The investment comes as Vive Organic’s annual sales have been growing by 400% on average since its inception in 2015, and the overall wellness shot category continues to gain momentum amid the ongoing pandemic.
Share: